Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Alvarez-Cermeño, JC"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-17 z 17
    Tytuł:
    Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course.
    Autorzy:
    Gil-Varea E; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
    Urcelay E; Immunology Department, Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria San Carlos (IdISSC), Madrid, Spain.
    Vilariño-Güell C; Department of Medical Genetics, University of British Columbia, Vancouver, Canada.
    Costa C; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
    Midaglia L; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
    Matesanz F; Department of Cell Biology and Immunology, Instituto de Parasitología y Biomedicina 'López Neyra', Consejo Superior de Investigaciones Científicas (IPBLN-CSIC), Granada, Spain.
    Rodríguez-Antigüedad A; Servicio de Neurología, Hospital Universitario Basurto-Osakidetza, Bilbao, Spain.
    Oksenberg J; Department of Neurology, University of California, San Francisco, CA, USA.
    Espino-Paisan L; Immunology Department, Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria San Carlos (IdISSC), Madrid, Spain.
    Dessa Sadovnick A; Department of Medical Genetics, University of British Columbia, Vancouver, Canada.
    Saiz A; Neurology Service, Hospital Clinic and Institut d'Investigació Biomèdica Pi i Sunyer (IDIBAPS), Barcelona, Spain.
    Villar LM; Departments of Immunology and Neurology, Multiple Sclerosis Unit, Hospital Ramon y Cajal, (IRYCIS), Madrid, Spain.
    García-Merino JA; Neuroimmunology Unit, Puerta de Hierro University Hospital and Research Institute, Universidad Autónoma de Madrid, Madrid, Spain.
    Ramió-Torrentà L; Neuroimmunology and Multiple Sclerosis Unit, Department of Neurology, Hospital Dr Josep Trueta, IDIBGI, University of Girona, Girona, Spain.
    Triviño JC; Genomic Systems, Valencia, Spain.
    Quintana E; Neuroimmunology and Multiple Sclerosis Unit, Department of Neurology, Hospital Dr Josep Trueta, IDIBGI, University of Girona, Girona, Spain.
    Robles R; Neuroimmunology and Multiple Sclerosis Unit, Department of Neurology, Hospital Dr Josep Trueta, IDIBGI, University of Girona, Girona, Spain.
    Sánchez-López A; Neuroimmunology Unit, Puerta de Hierro University Hospital and Research Institute, Universidad Autónoma de Madrid, Madrid, Spain.
    Arroyo R; Servicio de Neurología, Hospital Universitario Quirón Salud, Madrid, Spain.
    Alvarez-Cermeño JC; Departments of Immunology and Neurology, Multiple Sclerosis Unit, Hospital Ramon y Cajal, (IRYCIS), Madrid, Spain.
    Vidal-Jordana A; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
    Malhotra S; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
    Fissolo N; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
    Montalban X; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
    Comabella M; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. .
    Pokaż więcej
    Źródło:
    Journal of neuroinflammation [J Neuroinflammation] 2018 Sep 14; Vol. 15 (1), pp. 265. Date of Electronic Publication: 2018 Sep 14.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Genetic Predisposition to Disease/*genetics
    Multiple Sclerosis/*genetics
    Multiple Sclerosis/*physiopathology
    Polymorphism, Single Nucleotide/*genetics
    Exome Sequencing/*methods
    Brain/metabolism ; Carboxypeptidases A/genetics ; Carboxypeptidases A/metabolism ; Cohort Studies ; Disease Progression ; Female ; Gene Frequency ; Genotype ; Humans ; Immunoglobulins/genetics ; Immunoglobulins/metabolism ; Male ; Multiple Sclerosis/pathology ; Nerve Tissue Proteins/genetics ; Nerve Tissue Proteins/metabolism ; RNA, Messenger
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients.
    Autorzy:
    Sadovnick AD; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada Division of Neurology, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada.
    Traboulsee AL; Division of Neurology, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada.
    Bernales CQ; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada.
    Ross JP; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada.
    Forwell AL; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada.
    Yee IM; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada.
    Guillot-Noel L; Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, France.
    Fontaine B; Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, France.
    Cournu-Rebeix I; Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, France.
    Alcina A; Department of Cell Biology and Immunology, Instituto de Parasitología y Biomedicina López Neyra (IPBLN), CSIC, 18100 Granada, Spain.
    Fedetz M; Department of Cell Biology and Immunology, Instituto de Parasitología y Biomedicina López Neyra (IPBLN), CSIC, 18100 Granada, Spain Unidad de Esclerosis Múltiple, Hospital Universitario Virgen Macarena, 41071 Sevilla, Spain.
    Izquierdo G; Unidad de Esclerosis Múltiple, Hospital Universitario Virgen Macarena, 41071 Sevilla, Spain.
    Matesanz F; Department of Cell Biology and Immunology, Instituto de Parasitología y Biomedicina López Neyra (IPBLN), CSIC, 18100 Granada, Spain.
    Hilven K; Laboratory for Neuroimmunology, Neurosciences, University of Leuven, 1022, Belgium.
    Dubois B; Laboratory for Neuroimmunology, Neurosciences, University of Leuven, 1022, Belgium Department of Neurology, University Hospitals Leuven, University of Leuven, Belgium.
    Goris A; Laboratory for Neuroimmunology, Neurosciences, University of Leuven, 1022, Belgium.
    Astobiza I; Neurogenomiks Group, Universidad del País Vasco (UPV/EHU), 48940 Spain Achucarro Basque Center for Neuroscience, 48170 Spain.
    Alloza I; Neurogenomiks Group, Universidad del País Vasco (UPV/EHU), 48940 Spain Achucarro Basque Center for Neuroscience, 48170 Spain IKERBASQUE, Basque Foundation for Science, 48011 Spain.
    Antigüedad A; Servicio de Neurología, Hospital Universitario Basurto-Osakidetza, 48940 Bilbao, Spain.
    Vandenbroeck K; Neurogenomiks Group, Universidad del País Vasco (UPV/EHU), 48940 Spain Achucarro Basque Center for Neuroscience, 48170 Spain IKERBASQUE, Basque Foundation for Science, 48011 Spain.
    Akkad DA; Department of Human Genetics, Ruhr University, 44801 Bochum, Germany.
    Aktas O; Department of Neurology, Medical Faculty, Heinrich Heine University, 40225 Düsseldorf, Germany.
    Blaschke P; Department of Neurology, University of Rostock, 18059 Germany.
    Buttmann M; Department of Neurology, University of Würzburg, 97080 Würzburg, Germany.
    Chan A; Department of Neurology, University Hospital Bern and University of Bern, 3010 Bern, Switzerland.
    Epplen JT; Department of Human Genetics, Ruhr University, 44801 Bochum, Germany.
    Gerdes LA; Institute for Clinical Neuroimmunology, Ludwig Maximilian University, 80539 Munich, Germany.
    Kroner A; Department of Neurology, University of Würzburg, 97080 Würzburg, Germany Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, WI 53226.
    Kubisch C; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
    Kümpfel T; Institute for Clinical Neuroimmunology, Ludwig Maximilian University, 80539 Munich, Germany.
    Lohse P; Department of Clinical Chemistry, Ludwig Maximilian University, 80539 Munich, Germany Institute of Laboratory Medicine and Human Genetics, 78224 Singen, Germany.
    Rieckmann P; Department of Neurology, University of Würzburg, 97080 Würzburg, Germany Department of Neurology, Sozialstiftung Bamberg Hospital, 96049 Germany.
    Zettl UK; Department of Neurology, University of Rostock, 18059 Germany.
    Zipp F; Department of Neurology, Focus Program Translational Neuroscience, University Medical Center of the Johannes Gutenberg-University Mainz, 55122 Germany.
    Bertram L; Lübeck Interdisciplinary Platform for Genome Analytics, Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, 23562, Germany School of Public Health, Medicine, Imperial College London, SW7 2AZ, UK.
    Lill CM; Department of Neurology, Focus Program Translational Neuroscience, University Medical Center of the Johannes Gutenberg-University Mainz, 55122 Germany Lübeck Interdisciplinary Platform for Genome Analytics, Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, 23562, Germany Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, 08035 Spain.
    Fernandez O; Department of Neurology, UGC Neurociencias Clínicas. IBIMA-Hospital Regional Universitario de Málaga, 29010 Spain.
    Urbaneja P; Department of Neurology, UGC Neurociencias Clínicas. IBIMA-Hospital Regional Universitario de Málaga, 29010 Spain.
    Leyva L; Research Laboratory, UGC Neurociencias Clínicas. IBIMA-Hospital Regional Universitario de Málaga, 29010 Spain.
    Alvarez-Cermeño JC; Immunology and Neurology Service, Multiple Sclerosis Unit, Ramón y Cajal University Hospital-IRYCIS, 28034 Madrid, Spain.
    Arroyo R; Department of Neurology, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos-IdISSC, 28040 Madrid, Spain.
    Garagorri AM; Department of Immunology, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos-IdISSC, Madrid, Spain.
    García-Martínez A; Department of Immunology, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos-IdISSC, Madrid, Spain.
    Villar LM; Immunology and Neurology Service, Multiple Sclerosis Unit, Ramón y Cajal University Hospital-IRYCIS, 28034 Madrid, Spain.
    Urcelay E; Department of Immunology, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos-IdISSC, Madrid, Spain.
    Malhotra S; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, 08035 Spain.
    Montalban X; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, 08035 Spain.
    Comabella M; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, 08035 Spain.
    Berger T; Department of Clinical Neurology, Medical University of Innsbruck, 6020 Austria.
    Fazekas F; Department of Neurology, Medical University of Graz, 8010 Austria.
    Reindl M; Department of Clinical Neurology, Medical University of Innsbruck, 6020 Austria.
    Schmied MC; Department of Neurology, Medical University of Vienna, 1090 Austria.
    Zimprich A; Department of Neurology, Medical University of Vienna, 1090 Austria.
    Vilariño-Güell C; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada .
    Pokaż więcej
    Źródło:
    G3 (Bethesda, Md.) [G3 (Bethesda)] 2016 Jul 07; Vol. 6 (7), pp. 2073-9. Date of Electronic Publication: 2016 Jul 07.
    Typ publikacji:
    Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Polymorphism, Single Nucleotide*
    Chromosomes, Human, Pair 6/*chemistry
    Multiple Sclerosis/*genetics
    Plasminogen/*genetics
    Adult ; Aged ; Amino Acid Sequence ; Case-Control Studies ; Chromosomes, Human, Pair 6/metabolism ; Exome ; Female ; Gene Expression ; Genotype ; Humans ; Male ; Middle Aged ; Multiple Sclerosis/pathology ; Pedigree ; Risk Factors ; Sequence Alignment ; Sequence Homology, Amino Acid
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-Analysis.
    Autorzy:
    Ortiz MA; Immunology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.
    Núñez C; Immunology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.
    Ordóñez D; Immunogenetics & Histocompatibility, Instituto de Investigación Sanitaria Puerta de Hierro, Majadahonda, Madrid, Spain.
    Alvarez-Cermeño JC; Departments of Immunology and Neurology, Multiple Sclerosis Unit, Hospital Ramon y Cajal, (IRYCIS), Madrid, Spain.
    Martínez-Rodriguez JE; Neurology, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
    Sánchez AJ; Neuroimmunology, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
    Arroyo R; Multiple Sclerosis Unit, Neurology Department. Hospital Clínico S. Carlos, Instituto de Investigación Sanitaria S. Carlos (IdISSC), Madrid, Spain.
    Izquierdo G; Multiple Sclerosis Unit, Hospital Virgen Macarena, Sevilla, Spain.
    Malhotra S; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
    Montalban X; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
    García-Merino A; Neuroimmunology, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
    Munteis E; Neurology, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
    Alcina A; Department of Cell Biology and Immunology, Instituto de Parasitología y Biomedicina 'López Neyra', Consejo Superior de Investigaciones Científicas (IPBLN-CSIC), Granada, Spain.
    Comabella M; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
    Matesanz F; Department of Cell Biology and Immunology, Instituto de Parasitología y Biomedicina 'López Neyra', Consejo Superior de Investigaciones Científicas (IPBLN-CSIC), Granada, Spain.
    Villar LM; Departments of Immunology and Neurology, Multiple Sclerosis Unit, Hospital Ramon y Cajal, (IRYCIS), Madrid, Spain.
    Urcelay E; Immunology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2015 Aug 14; Vol. 10 (8), pp. e0134414. Date of Electronic Publication: 2015 Aug 14 (Print Publication: 2015).
    Typ publikacji:
    Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Gene Deletion*
    Multiple Sclerosis/*genetics
    Receptors, Immunologic/*genetics
    Epistasis, Genetic ; Genetic Association Studies ; Genetic Predisposition to Disease ; HLA-DRB1 Chains/genetics ; Humans ; White People/legislation & jurisprudence
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Comparative diagnostic accuracy of ganglion cell-inner plexiform and retinal nerve fiber layer thickness measures by Cirrus and Spectralis optical coherence tomography in relapsing-remitting multiple sclerosis.
    Autorzy:
    González-López JJ; Department of Ophthalmology, Ramón y Cajal University Hospital, Carretera de Colmenar Km 9, 1, 28034 Madrid, Spain ; Department of Surgery, Alcalá de Henares University, Madrid, Spain ; Medical Retina Department, Moorfields Eye Hospital, London, UK.
    Rebolleda G; Department of Ophthalmology, Ramón y Cajal University Hospital, Carretera de Colmenar Km 9, 1, 28034 Madrid, Spain ; Department of Surgery, Alcalá de Henares University, Madrid, Spain.
    Leal M; Department of Ophthalmology, Ramón y Cajal University Hospital, Carretera de Colmenar Km 9, 1, 28034 Madrid, Spain.
    Oblanca N; Department of Ophthalmology, Ramón y Cajal University Hospital, Carretera de Colmenar Km 9, 1, 28034 Madrid, Spain.
    Muñoz-Negrete FJ; Department of Ophthalmology, Ramón y Cajal University Hospital, Carretera de Colmenar Km 9, 1, 28034 Madrid, Spain ; Department of Surgery, Alcalá de Henares University, Madrid, Spain.
    Costa-Frossard L; Department of Neurology, Ramón y Cajal University Hospital, Madrid, Spain.
    Alvarez-Cermeño JC; Department of Neurology, Ramón y Cajal University Hospital, Madrid, Spain.
    Pokaż więcej
    Źródło:
    BioMed research international [Biomed Res Int] 2014; Vol. 2014, pp. 128517. Date of Electronic Publication: 2014 Sep 18.
    Typ publikacji:
    Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Multiple Sclerosis, Relapsing-Remitting/*diagnosis
    Multiple Sclerosis, Relapsing-Remitting/*pathology
    Nerve Fibers/*pathology
    Retinal Ganglion Cells/*pathology
    Tomography, Optical Coherence/*methods
    Adult ; Case-Control Studies ; Demography ; Female ; Humans ; Male ; Multiple Sclerosis, Relapsing-Remitting/complications ; Multiple Sclerosis, Relapsing-Remitting/physiopathology ; Optic Neuritis/complications ; Optic Neuritis/pathology ; Optic Neuritis/physiopathology ; Sensitivity and Specificity
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    B cells capable of spontaneous IgG secretion in cerebrospinal fluid from patients with multiple sclerosis: dependency on local IL-6 production.
    Autorzy:
    Perez L; Servicio de Inmunología, Hospital Puerta del Mar, Cádiz, Spain.
    Alvarez-Cermeño JC
    Rodriguez C
    Roldán E
    Brieva JA
    Pokaż więcej
    Źródło:
    Clinical and experimental immunology [Clin Exp Immunol] 1995 Sep; Vol. 101 (3), pp. 449-52.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    B-Lymphocytes/*immunology
    Immunoglobulin G/*biosynthesis
    Interleukin-6/*metabolism
    Multiple Sclerosis/*cerebrospinal fluid
    Adult ; B-Lymphocytes/metabolism ; Cells, Cultured ; Culture Media, Serum-Free ; Female ; Humans ; Interleukin-6/pharmacology ; Male ; Multiple Sclerosis/immunology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Soluble HLA class I antigen secretion by normal lymphocytes: relationship with cell activation and effect of interferon-gamma.
    Autorzy:
    Brieva JA; Servicio de Inmunologia, Hospital Ramón y Cajal, Madrid, Spain.
    Villar LM
    Leoro G
    Alvarez-Cermeño JC
    Roldán E
    Gonzalez-Porqué P
    Pokaż więcej
    Źródło:
    Clinical and experimental immunology [Clin Exp Immunol] 1990 Nov; Vol. 82 (2), pp. 390-5.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Lymphocyte Activation*
    Histocompatibility Antigens Class I/*metabolism
    Interferon-gamma/*pharmacology
    Lymphocytes/*metabolism
    B-Lymphocytes/metabolism ; Cells, Cultured ; Enzyme-Linked Immunosorbent Assay ; Humans ; Kinetics ; Lymphocytes/immunology ; Solubility ; T-Lymphocytes/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-17 z 17

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies